R. Chlebowski, L. Kuller, and R. Prentice, Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women, New England Journal of Medicine, vol.360, issue.6, pp.573-587, 2009.
DOI : 10.1056/NEJMoa0807684

A. Fournier, F. Berrino, and F. Clavel-chapelon, Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study, Breast Cancer Research and Treatment, vol.95, issue.1, pp.103-111, 2008.
DOI : 10.1007/s10549-007-9523-x

URL : https://hal.archives-ouvertes.fr/inserm-00201813

V. Ringa and A. Fournier, Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?, Revue d'??pid??miologie et de Sant?? Publique, vol.56, issue.5, pp.8-12, 2008.
DOI : 10.1016/j.respe.2008.09.001